Skip to main navigation
Avadel Pharmaceuticals
  • Recent News
  • Investors
  • About
    • Overview
    • Leadership
    • Board of Directors
    • Business Development
    • Corporate Responsibility
  • Research
    • Clinical Trials
  • Contact Us
  • Call Today
  • Email Us
  • Our Map
    • Avadel Pharmaceuticals
    • 636.449.1830
    • Home
    • About
      • Overview
      • Leadership
      • Board of Directors
      • Business Development
      • Corporate Responsibility
    • Research Pipeline
      • Clinical Trials
    • Investor Relations

      • Investors
      • News & Events
        • Press Releases
        • Events
        • Presentations
      • Stock Information
        • Stock Quote & Chart
        • Historical Price Lookup
        • Investment Calculator
        • Analyst Coverage
      • Financial Information
        • SEC Filings
        • Financial Reports
        • Quarterly Results
      • Corporate Governance
        • Governance Highlights
        • Management Team
        • Board of Directors
        • Committee Composition
        • Annual General Meeting
      • Shareholder Services
        • Investor FAQs
        • Information Request
        • E-mail Alerts
        • IR Contacts
    • Contact Us
646.449.1830

Breadcrumb

  1. Home
  2. Investors
  3. SEC Filings

SEC Filings

SEC Filing Keyword Search

Filing date Form Description Filing Group Downloads
12/05/19 4

Statement of changes in beneficial ownership of securities

3,4,5
0001104659-19-070213.rtf
0001104659-19-070213.pdf
12/05/19 4

Statement of changes in beneficial ownership of securities

3,4,5
0001104659-19-070217.rtf
0001104659-19-070217.pdf
12/03/19 3

Initial filing by director officer or owner of more than ten percent.

3,4,5
0001104659-19-069621.rtf
0001104659-19-069621.xls
0001104659-19-069621.pdf
12/03/19 4

Statement of changes in beneficial ownership of securities

3,4,5
0001104659-19-069622.rtf
0001104659-19-069622.pdf
12/02/19 8-K

Report of unscheduled material events or corporate event

Current Reports
0001104659-19-068803.rtf
0001104659-19-068803.xls
0001104659-19-068803.pdf
11/25/19 8-K

Report of unscheduled material events or corporate event

Current Reports
0001104659-19-066833.rtf
0001104659-19-066833.xls
0001104659-19-066833.pdf
11/21/19 8-K

Report of unscheduled material events or corporate event

Current Reports
0000910680-19-000084.rtf
0000910680-19-000084.xls
0000910680-19-000084.pdf
11/19/19 4

Statement of changes in beneficial ownership of securities

3,4,5
0001567619-19-021875.rtf
0001567619-19-021875.pdf
11/19/19 4

Statement of changes in beneficial ownership of securities

3,4,5
0001567619-19-021885.rtf
0001567619-19-021885.pdf
11/19/19 4

Statement of changes in beneficial ownership of securities

3,4,5
0001567619-19-021887.rtf
0001567619-19-021887.pdf
11/14/19 4

Statement of changes in beneficial ownership of securities

3,4,5
0001567619-19-021625.rtf
0001567619-19-021625.pdf
11/14/19 3

Initial filing by director officer or owner of more than ten percent.

3,4,5
0001567619-19-021621.rtf
0001567619-19-021621.xls
0001567619-19-021621.pdf
11/12/19 8-K

Report of unscheduled material events or corporate event

Current Reports
0001104659-19-062085.rtf
0001104659-19-062085.xls
0001104659-19-062085.pdf
11/12/19 10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
0001012477-19-000012.rtf
0001012477-19-000012.xls
0001012477-19-000012.pdf
EX-101.INS - XBRL INSTANCE DOCUMENT
10/07/19 SC 13G/A

An amendment to the SC 13G filing

Other
0000919574-19-006246.rtf
0000919574-19-006246.xls
0000919574-19-006246.pdf
10/04/19 8-K

Report of unscheduled material events or corporate event

Current Reports
0000910680-19-000072.rtf
0000910680-19-000072.xls
0000910680-19-000072.pdf
10/04/19 SC 13D/A

An amendment to a SC 13D filing

Other
0000919574-19-006239.rtf
0000919574-19-006239.xls
0000919574-19-006239.pdf
09/25/19 8-K

Report of unscheduled material events or corporate event

Current Reports
0001144204-19-045950.rtf
0001144204-19-045950.xls
0001144204-19-045950.pdf
09/24/19 8-K

Report of unscheduled material events or corporate event

Current Reports
0001144204-19-045690.rtf
0001144204-19-045690.xls
0001144204-19-045690.pdf
09/24/19 8-K

Report of unscheduled material events or corporate event

Current Reports
0001144204-19-045727.rtf
0001144204-19-045727.xls
0001144204-19-045727.pdf

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Current page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

Tools

  • Print Page
  • RSS
  • E-mail Alerts

Investor Relations

  • Investors
  • News & Events
    • Press Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Financial Information
    • SEC Filings
    • Financial Reports
    • Quarterly Results
  • Corporate Governance
    • Governance Highlights
    • Management Team
    • Board of Directors
    • Committee Composition
    • Annual General Meeting
  • Shareholder Services
    • Investor FAQs
    • Information Request
    • E-mail Alerts
    • IR Contacts

Contact Avadel Pharmaceuticals Today

Avadel Pharmaceuticals

Helpful Links Site Map | Privacy Policy | Terms and Conditions

  • Overview
  • News & Events
  • Careers
  • Investors
  • Contact Us
16640 Chesterfield Grove Road,
Suite 200,
Saint Louis, MO 63005 |  View Map [+]
http://www.avadel.com/
Site Map | Privacy Policy
http://www.avadel.com/

© COPYRIGHT AVADEL PHARMACEUTICALS, PLC. ALL RIGHTS RESERVED

0117 AVL WBST MAIN_KP2